Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Ruxolitinib
Related studies linked through entity extraction aliases.
Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Actuate 1901: 9-ING-41 in Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
MITHRIDATE: Ruxolitinib Versus Hydroxycarbamide or Interferon as First Line Therapy in High Risk Polycythemia Vera
- Status
- RECRUITING
- Phase
- PHASE3
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
First Line Therapy for High Risk Acute GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Multi-Ctr PII Cmb.Modality Tx Ruxolitinib, Decitabine, and DLI for Post HSCT in AML/MDS
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Dual PD-1 and JAK2 Inhibition in Hematological Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE2
Ruxolitinib in Myelofibrosis Patients in Lombardy, Italy
- Status
- UNKNOWN
- Phase
- N/A
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders
- Status
- RECRUITING
- Phase
- PHASE2
Ruxolitinib Combined With Dexamethasone for HLH
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2